This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Evaluation of the Binding of Radiolabeled Rituximab to CD20-Positive Lymphoma Cells: An In Vitro Feasibility Study Concerning Low-Dose-Rate Radioimmunotherapy with the α-Emitter 227Th, Cancer Biotherapy & Radiopharmaceuticals, August 2007, Mary Ann Liebert Inc,
DOI: 10.1089/cbr.2007.371.
You can read the full text:
The following have contributed to this page
